The College of American Pathologists (CAP), the leading medical society for board-certified pathologists, announced today its recognition as one of Becker’s Healthcare “150 Great Places to Work in Healthcare.”
The College of American Pathologists (CAP) and the American Society of Cytopathology (ASC) announced today the signing of a memorandum of understanding (MOU) to collaborate on initiatives to advance the delivery of cytopathology services and improve patient care.
The College of American Pathologists was awarded more than $1.25 million by the Centers for Disease Control and Prevention (CDC) to improve adoption of evidence-based, laboratory testing guidelines and biomarker cancer reporting.
The College of American Pathologists has developed the first evidence-based guideline to validate all immunohistochemical (IHC) assays. The guideline, “Principles of Analytic Validation of Immunohistochemical Assays, is available in the online edition of Archives of Pathology & Laboratory Medicine.
Sometimes called the "doctor's doctor," pathologists are physicians who who use laboratory medicine and technology to identify and diagnose disease. Pathologists are responsible for analyzing everything from the human body—such as blood, fluids, and tissues— from before birth to after death.
CAP support of new study by Jean Mitchell, PhD, which presents evidence to end self-referral.
Leading pathology experts convene at College of American Pathologists annual meeting on October 13-15 at the Gaylord Palms in Orlando, Florida.
CAP supports legislation introduced by Rep Jackie Speier to end self-referral.
College of American Pathologists will host a free webinar on genomic analysis on Tuesday, July 23 from 2-3 p.m. CDT. Leading experts in the field will discuss current and future applications in pathology.
College of American Pathologist reacts to a new report from the GAO documenting millions of dollars in wasteful health care spending by physicians who self-refer anatomic pathology services.
Live expert panel discussion today, June 19, 2013, from 3-4 p.m. EDT on Supreme Court Ruling on gene patents.
College of American Pathologists applauds U.S. Supreme Court ruling on gene patents.
College of American Pathologists offers first evidence-based guideline for validating whole slide imaging.
New science molecular diagnostics, personalized medicine, and genetic testing for cancer will be featured topics when more than 1,000 pathology leaders gather at the Manchester Grand Hyatt on September 9-12, 2012, for the annual scientific meeting of the College of American Pathologists. The CAP'12--THE Pathologists' Meeting will highlight advances in anatomic and clinical pathology related to laboratory medicine with a special focus on pulmonary pathology, the diagnosis of lung disease.
The College of American Pathologists (CAP) published a revised version of its molecular pathology checklist with a dedicated section on next generation sequencing (NGS) as part of the new edition of the CAP Laboratory Accreditation Program checklists released July 31, 2012. The CAP is the first to publish an accreditation checklist that addresses NGS, advancing standardized practice in genomic testing.
The College of American Pathologists (CAP) and the American Society for Colposcopy and Cervical Pathology (ASCCP) jointly issued The Lower Anogenital Squamous Terminology (LAST) Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations.
The College of American Pathologists partners with CollabRx to provide decision support tools to patients.
Designed to help laboratories, organizations, and health care professionals better understand how to plan and resource quality management systems, these course offerings focus on improved patient care along with error prevention, risk reduction, and cost control.
New science in cancer, genetic testing, molecular diagnostics, medical ethics, and gender-based disorders will be featured topics when nearly 1,200 pathologists gather at the Hyatt Regency Chicago on September 26 – 29 for the annual scientific meeting of the College of American Pathologists (CAP). CAP ’10 – The Pathologists’ Meeting™ will highlight advances in anatomic and clinical pathology with a special focus on gender-based disorders, including male pathology issues such as infertility, testicular tumors, and prostate cancer.
High-quality biospecimens, samples such as tissue or blood used for diagnosis, are essential to the advancement of molecular testing, and pathologists are using cutting edge technologies to help improve diagnostics of biospecimens. At its annual meeting, the College of American Pathologists (CAP) will host an educational session titled “Comprehending the Critical Role of Biospecimens in Personalized Health Care.”
DNA-based tests can help doctors detect genetic disorders and identify if someone is prone or likely to develop certain conditions or diseases, including autosomal dominant disorders such as cancer, Alzheimer’s disease and Huntington’s disease. Testing for these types of disorders raises important ethical considerations and questions, including those around testing in children. To bring expert insight into the discussion around genetic testing, the College of American Pathologists (CAP) will host an educational session at its annual meeting.
Infertility can affect 15 percent of couples. In nearly half of these couples, the inability to conceive may be due to male infertility. Not only do pathologists play a key role in identifying the issue, but oftentimes they help to determine viable assisted reproductive technologies. This session provides information that will help pathologists better diagnose infertility and enhance clinicians’ recommendations for treatment options.
To draw attention to the screening and diagnosis of ovarian cancer, the College of American Pathologists (CAP) will host an educational session at its annual meeting titled “Ovarian Carcinomas and Tumors of Low Malignant Potential: A Practical Review.” The session will provide an intensive review of ovarian carcinomas and tumors of low malignant potential to help pathologists deliver high-quality patient care. Experts will also be available to discuss the diagnosis of breast cancer and pre-cancerous conditions. Patients are available for media interviews.
The Prostate Specific Antigen (PSA) test was developed to help detect prostate cancer in men, however, some in the medical community question whether routine screening leads to unnecessary anxiety and worry among patients. The College of American Pathologists (CAP) will host an educational session at its annual meeting titled “PSA Testing – To Screen or Not to Screen?”that will include leading doctors in the fields of urology and pathology who will delve into both sides of the debate.
The College of American Pathologists (CAP) awarded six Chicago high school students the College’s 2010 “Path to a Future in Medicine” award. The students were invited to attend and display their winning projects at the College’s annual meeting, CAP ’10 – THE Pathologists’ Meeting™, on Sunday, September 26 at the Hyatt Regency Chicago.
The College of American Pathologists (CAP) recently signed Memoranda of Understanding (MOUs) with the Canadian Association of Pathologists (CAP-ACP) and the Royal College of Pathologists Australasia (RCPA), forging a collaboration in the development of cancer datasets, also called protocols. The CAP Cancer Protocols are designed as a guideline for definitive cancer reporting. This collaboration agreement not only allows pathologists from many different countries to participate actively in developing cancer protocols, but also helps better define staging parameters for cancer specimens.
The College of American Pathologists (CAP) recently signed Memoranda of Understanding (MOUs) with the Canadian Association of Pathologists (CAP-ACP) and the Royal College of Pathologists Australasia (RCPA), forging a collaboration in the development of cancer datasets, also called protocols. The CAP Cancer Protocols are designed as a guideline for definitive cancer reporting.
CAP’10—THE Pathologists’ Meeting™ Features the Latest in Cancer and Genetic Testing, Molecular Diagnostics, Medical Ethics, and Gender-based Disorders
Recent media reports of potential misdiagnosis of early-stage breast cancer may frighten women away from breast cancer screening that could save their lives. Rather than shying away from screening, women should know the questions to ask and be confident about weighing their options.
The College of American Pathologists (CAP) and the American Society of Clinical Oncology (ASCO) today issued a joint guideline aimed at improving the accuracy of immunohistochemistry (IHC) testing for the expression status of estrogen (ER) and progesterone receptors (PgR) in breast cancer.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right